ProKidney Corp.
PROK • NASDAQ
ProKidney Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bruce Culleton, with a market cap of $227.1M.
CEOBruce Culleton
Next Earnings
Upcoming earnings announcement for ProKidney Corp.
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.13
Revenue Estimate
$88.2K
Earnings History
Past 12 earnings reports for ProKidney Corp.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.14Est: -$0.15 | +6.7% | $225.0KEst: $100.4K | +124.2% | — |
| Nov 10, 2025 | Q3 2025 | -$0.12Est: -$0.13 | +7.7% | $217.0KEst: $44.3K | +390.4% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.13Est: -$0.14 | +7.1% | $221.0K | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.13Est: -$0.15 | +13.3% | $230.0K | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.16Est: -$0.15 | -6.7% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.14Est: -$0.15 | +6.7% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.16Est: -$0.17 | +5.9% | - | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$0.16Est: -$0.18 | +11.1% | - | — | 10-Q |
| Mar 22, 2024 | Q4 2023 | -$0.09 | — | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.18Est: -$0.16 | -12.5% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.14 | — | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.16Est: -$0.39 | +59.0% | - | — | 10-Q |